EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice

Esraa M Zeidan, Sai Aparna Nagarajan, Akylbek Sydykov, Jens Bier, Monika Brosien, Ashraf Taye, Oleg Pak, Hossein A Ghofrani, Ralph Theo Schermuly, Werner Seeger, Norbert Weissmann, Natascha Sommer iD and 1 more

Physiological Reports · 2026

DOI: 10.14814/phy2.70804 ↗

At a glance

Journal article in Physiological Reports, 2026. Written by Esraa M Zeidan and 12 co-authors. Institution: Excellence Cluster Cardio-Pulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Rese…. Major MEDLINE topics: Hypertension, Pulmonary, Organophosphorus Compounds, Hypoxia, Antioxidants. Cited 2 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft (DFG), Cardio-Pulmonary Institute (CPI), Deutsche Forschungsgemeinschaft (DFG) and NSF (National Science Foundation).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Mitochondrial reactive oxygen species (mtROS) have been implicated in the development of chronic hypoxia‐induced pulmonary hypertension (PH), potentially through hypoxia‐inducible factor‐1α (HIF‐1α) stabilization. However, the role of mtROS in HIF‐1α stabilization, PH development, and the therapeutic potential of antioxidant treatment remains controversial. Mice were exposed to hypoxia (10% O 2 ) for 4 weeks to induce PH and treated with mitochondria‐targeted antioxidant mitoTEMPO or its carrier control, triphenylphosphonium (TPP + ). Cell proliferation was evaluated in mouse pulmonary arterial smooth muscle cells (PASMCs) by BrdU incorporation. HIF‐1α stabilization and downstream target expression were investigated in mouse lung carcinoma epithelial (CMT167) cells and isolated mouse and human PASMCs under different hypoxic conditions. In vivo mitoTEMPO treatment did not affect chronic hypoxia‐induced PH compared to TPP + . In vitro, mitoTEMPO treatment did not inhibit hypoxia‐induced mouse PASMCs proliferation but enhanced proliferation under normoxic conditions. In vitro exposure of CMT167 cells and mouse or human PASMCs to mitoTEMPO or TPP + did not alter HIF‐1α protein levels or expression of its downstream targets lactate dehydrogenase A ( Ldha ) and pyruvate dehydrogenase kinase 1 ( Pdk1 ) under normoxic (21% O 2 ) or hypoxic (1% or 10% O 2 ) conditions after 24 h. These findings do not support a therapeutic benefit of mitoTEMPO in hypoxia‐induced PH.

Subjects

MeSH terms (MEDLINE)

Hypertension, PulmonaryOrganophosphorus CompoundsHypoxiaAntioxidantsAnimalsMaleHypoxia-Inducible Factor 1, alpha SubunitHumansMiceCell ProliferationMyocytes, Smooth MusclePulmonary ArteryMice, Inbred C57BLReactive Oxygen SpeciesPiperidines

Author keywords

HIF‐1αchronic hypoxiamitoTEMPOpulmonary hypertension

Substances

Organophosphorus CompoundsHypoxia-Inducible Factor 1, alpha SubunitMitoTEMPOAntioxidantsReactive Oxygen SpeciesHif1a protein, mousePiperidines

Authors and institutions

  • Excellence Cluster Cardio-Pulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, Giessen, Germany.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, El-Minia, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, South Valley University, Qena, Egypt.
  • Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen, Giessen, Germany.

ORCID profiles: Natascha Sommer, Claudio Nardiello

Funding

  • Deutsche Forschungsgemeinschaft (DFG)
  • Cardio-Pulmonary Institute (CPI)
  • Deutsche Forschungsgemeinschaft (DFG) and NSF (National Science Foundation)
  • National Science Foundation

Cite

APA

Zeidan, E. M., Nagarajan, S. A., Sydykov, A., Bier, J., Brosien, M., Taye, A., Pak, O., Ghofrani, H. A., Schermuly, R. T., Seeger, W., Weissmann, N., Sommer, N., & Nardiello, C. (2026). The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice. Physiological Reports. https://doi.org/10.14814/phy2.70804

Vancouver

Zeidan EM, Nagarajan SA, Sydykov A, Bier J, Brosien M, Taye A, et al. The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice. Physiological Reports. 2026. doi:10.14814/phy2.70804

BibTeX
@article{Zeidan2026,
  author = {Zeidan, Esraa M and Nagarajan, Sai Aparna and Sydykov, Akylbek and Bier, Jens and Brosien, Monika and Taye, Ashraf and Pak, Oleg and Ghofrani, Hossein A and Schermuly, Ralph Theo and Seeger, Werner and Weissmann, Norbert and Sommer, Natascha and Nardiello, Claudio},
  title = {The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice},
  journal = {Physiological Reports},
  year = {2026},
  doi = {10.14814/phy2.70804}
}
Start for free →